Viagra® is one of the most recognizable sexual-health medications in the world.

So it is understandable that women ask:

Can women take Viagra too?

The answer is more complicated than a simple yes or no.

Sildenafil—the active ingredient in Viagra—has been studied in women, and some clinical trials have reported improvements in certain aspects of sexual function in carefully selected groups.

Other trials have found no meaningful benefit at all.

And Viagra itself is not FDA-approved to treat female sexual dysfunction. Its approved sexual-health indication is erectile dysfunction.

Why are the results so inconsistent?

One major reason is that female sexual function is not one single process.

Desire, subjective arousal, genital arousal, lubrication, orgasm and sexual comfort are related—but they are not interchangeable.

Sildenafil primarily acts on a blood-flow pathway.

That makes it biologically plausible that it could influence some aspects of genital arousal.

But increasing genital blood flow is not the same thing as creating sexual desire.

That distinction explains much of what the research actually shows.

The Short Answer

Sildenafil has been studied and prescribed off-label in women, but Viagra is not FDA-approved to treat female sexual dysfunction.

Research in women has produced mixed results.

A large randomized trial involving 781 women with a broad range of sexual difficulties found no significant advantage for sildenafil over placebo.

But another randomized study involving 202 carefully selected postmenopausal women with female sexual arousal disorder—without concomitant HSDD or major contributing emotional or relationship factors—reported benefit from sildenafil.

A separate randomized trial involving 98 women with antidepressant-associated sexual dysfunction also found better sexual-function outcomes with sildenafil than placebo.

And in 2024, researchers studied an investigational topical sildenafil cream in 200 women with female sexual arousal disorder. That trial did not meet its main efficacy endpoints in the overall study population, although an exploratory subgroup showed improvements in several sexual-function measures. The primary paper confirms that 200 women were randomized and 174 completed the study.

So the most accurate conclusion is:

Sildenafil is not an established universal treatment for female sexual dysfunction. Its potential relevance appears to depend heavily on what type of sexual problem a woman is experiencing.

What Is Viagra?

Viagra is the brand name for sildenafil, a phosphodiesterase type 5 inhibitor, or PDE5 inhibitor.

Its FDA-approved sexual-health indication is erectile dysfunction.

During sexual stimulation, nitric oxide contributes to increased cyclic guanosine monophosphate, or cGMP.

PDE5 breaks down cGMP.

Sildenafil inhibits PDE5, allowing the cGMP pathway to remain active longer and supporting smooth-muscle relaxation and increased blood flow.

In erectile tissue, that can support the physical process involved in developing and maintaining an erection.

But that raises an obvious question:

If Viagra was developed for erectile dysfunction, why has sildenafil been studied in women at all?

Why Have Researchers Studied Sildenafil in Women?

Female genital arousal also involves vascular changes.

During sexual stimulation, increased genital blood flow contributes to physiologic responses involving:

• clitoral engorgement
• vaginal vasocongestion
• genital sensation
• lubrication-related responses

Researchers therefore investigated whether enhancing the nitric oxide/cGMP pathway could influence the physical genital-arousal response in women.

The idea was biologically plausible.

But sexual response in women is considerably more complex than genital blood flow alone.

A woman can experience:

mental desire without strong genital arousal

or:

genital arousal without strong subjective desire

She may also experience difficulty with orgasm, pain during sex or loss of sexual interest even when genital blood flow is not the primary problem.

That distinction turned out to matter enormously in sildenafil research.

Does Viagra Increase Sex Drive in Women?

There is not good evidence supporting sildenafil as a general treatment for female low sexual desire.

This is one of the most important distinctions in the entire discussion.

Sildenafil's pharmacologic target is a PDE5-mediated vascular pathway.

It was not developed as a medication targeting sexual desire.

And Viagra is not FDA-approved for hypoactive sexual desire disorder, or HSDD.

Clinical research also suggests that women whose primary problem is desire may respond differently from women whose primary problem is physical genital arousal.

One particularly important study illustrates this.

The 2003 Postmenopausal Study

Researchers evaluated sildenafil in 202 postmenopausal women with female sexual arousal disorder in a 12-week randomized, double-blind, placebo-controlled study.

Importantly, the women were selected to have female sexual arousal disorder as the primary diagnosis.

The researchers reported benefit particularly among women without concomitant hypoactive sexual desire disorder and without major emotional, relationship or historical factors contributing to their sexual difficulties.

That detail is critical.

It suggests that sildenafil may have been more relevant when the primary problem involved arousal response rather than absent sexual desire.

It does not establish Viagra as a libido medication for women.

Desire and Arousal Are Not the Same Thing

This distinction deserves its own section because it explains why headlines such as “Viagra for women” can be misleading.

Consider four different experiences:

“I rarely feel interested in sex.”

That primarily describes a desire concern.

“I want sex, but my body doesn't seem to respond.”

That may involve subjective or genital arousal.

“I become aroused but have trouble reaching orgasm.”

That is primarily an orgasm-related concern.

“Sex has become uncomfortable or painful.”

That involves comfort or pain, which requires a different evaluation.

Sildenafil primarily targets a vascular pathway.

It cannot be assumed to address every step of sexual response simply because these experiences may sometimes occur together.

This is also why one medication should not automatically be described as a general treatment for “female sexual dysfunction.”

Related reading: Low Libido in Women: Causes, HSDD and Treatment Options in 2026

What Does the Largest Oral Sildenafil Trial in Women Show?

One of the most important sildenafil studies in women produced a negative result.

Researchers conducted a randomized, placebo-controlled trial involving:

• 577 estrogenized women
• 204 estrogen-deficient women

for a total of 781 participants.

The participants had a broad spectrum of sexual dysfunction that included female sexual arousal disorder.

Participants received sildenafil or placebo.

The researchers found no statistically significant difference between sildenafil and placebo across the efficacy outcomes studied.

Their conclusion was especially informative:

Any physiologic genital effect of sildenafil did not translate into improved overall sexual response in this broad population.

That is a major reason it would be inaccurate to say:

“Viagra works for female sexual dysfunction.”

The evidence does not support such a broad statement.

But it also does not mean sildenafil has shown no signal in any women.

More narrowly selected trials tell a more nuanced story.

Can Sildenafil Help Female Sexual Arousal?

Possibly in certain selected populations, but the evidence is mixed.

The 202 postmenopausal women studied in the 2003 randomized trial were much more narrowly selected than participants in the larger negative trial.

They had female sexual arousal disorder without concomitant HSDD or major emotional and relationship contributors, and the trial reported benefit with sildenafil.

Other smaller controlled studies have investigated sildenafil in specific populations.

For example, a randomized crossover study in premenopausal women with type 1 diabetes and genital-arousal difficulties reported changes in subjective sexual measures and clitoral vascular measurements.

Only 32 women completed that study, however, which substantially limits how broadly the findings can be applied.

A small controlled study in women with spinal cord injury also reported sexual-response effects, but included only 19 women and called for larger studies.

Taken together, these studies suggest something much narrower than:

“Viagra works for women.”

A more accurate interpretation is:

Certain subgroups of women with predominantly physical or genital-arousal difficulties have shown signals of benefit in clinical studies, but sildenafil has not demonstrated consistent effectiveness across female sexual dysfunction as a whole.

Can Viagra Help Women Taking Antidepressants?

This is one of the more interesting sildenafil findings in women.

Some serotonin reuptake inhibitor antidepressants can be associated with changes in sexual function.

In 2008, researchers conducted an eight-week randomized, double-blind, placebo-controlled trial involving 98 women whose depression was in remission while taking serotonin reuptake inhibitors but who were experiencing sexual dysfunction.

The participants had previously been sexually functioning, and their mean age was approximately 37 years.

Forty-nine women received sildenafil and 49 received placebo.

The sildenafil group showed significantly better results on the trial's primary sexual-function outcome than the placebo group.

At the beginning of the study, participants reported concerns that could include:

• decreased libido
• arousal difficulties
• lubrication difficulties
• delayed orgasm
• other orgasm difficulties

The researchers concluded that sildenafil was associated with a reduction in adverse sexual effects in this specific population of women taking serotonin reuptake inhibitors.

But the finding needs to be interpreted carefully.

This was a specific group of 98 women with antidepressant-associated sexual dysfunction.

It does not establish sildenafil as a general treatment for female low libido or female sexual dysfunction.

And it does not mean someone should independently add sildenafil to an antidepressant regimen.

Medication-related sexual changes should be discussed with the healthcare professional managing the underlying treatment.

Does Viagra Help Women Reach Orgasm?

Sildenafil has been studied in women experiencing orgasm difficulties, but it is not an FDA-approved treatment for female orgasmic disorder.

The antidepressant-associated sexual dysfunction study included women experiencing delayed orgasm and other orgasm-related difficulties and reported overall improvement in sexual-function outcomes with sildenafil compared with placebo.

Other smaller studies have investigated orgasm-related responses as well.

But the evidence is not consistent or broad enough to say that sildenafil predictably improves orgasm in women generally.

Again, the specific sexual concern matters.

Desire, genital arousal and orgasm are separate clinical questions.

Does Viagra Work for Women After Menopause?

Studies have produced conflicting results.

Two important trials illustrate this particularly well.

A broad negative trial

The 2002 study involving 781 estrogenized and estrogen-deficient women found no significant improvement with sildenafil across the major efficacy outcomes.

A more narrowly selected positive trial

The 2003 study involving 202 postmenopausal women with primary female sexual arousal disorder reported benefit in women without concomitant HSDD or major emotional or relationship contributors.

These apparently conflicting findings reinforce the main point of this article:

“Female sexual dysfunction” is too broad a category to predict whether sildenafil will be relevant.

A postmenopausal woman whose primary concern is low sexual desire may have a very different clinical picture from a woman who experiences desire but notices reduced genital arousal.

Menopause-related dryness, discomfort, medications, relationship factors, hormonal changes and other health issues can also influence sexual wellbeing independently of genital blood flow.

What About Topical Sildenafil for Women?

This is an emerging area of research—but it should not be confused with taking oral Viagra.

In 2024, researchers published a phase 2b randomized, double-blind, placebo-controlled study of 3.6% topical sildenafil cream in premenopausal women with female sexual arousal disorder.

The primary study report states that:

• 200 women were randomized
• 101 received sildenafil cream
• 99 received placebo cream
• 174 women completed the study
• 90 completed in the sildenafil group
• 84 completed in the placebo group

In the full intention-to-treat population, the sildenafil cream group showed greater improvement on some measures, but there were no statistically significant differences between sildenafil and placebo on the coprimary or secondary efficacy endpoints. The study therefore did not establish overall efficacy on its primary outcomes.

What Did the Exploratory Subgroup Show?

Researchers also performed an exploratory post hoc analysis.

The subgroup included women with female sexual arousal disorder with or without concomitant decreased desire, while excluding certain other concomitant sexual dysfunctions.

In that subgroup, sildenafil cream was associated with greater improvement in:

• arousal sensation
• desire
• orgasm measures
• several measures of sexual distress and interpersonal difficulty

compared with placebo.

Those findings are interesting.

But two limitations are essential.

First, this was an exploratory subgroup analysis.

A post hoc subgroup result is weaker evidence than a trial successfully meeting its prespecified primary endpoints in the overall population.

Second, topical sildenafil cream is not oral Viagra.

Formulation, route of administration and systemic exposure differ.

Evidence from an investigational topical formulation should therefore not automatically be transferred to oral sildenafil—or vice versa.

So Does Sildenafil Work for Women?

The most accurate answer is:

Sometimes in research settings and selected populations—but not consistently enough to treat sildenafil as a universal female sexual-health medication.

The research suggests that results can differ depending on:

• what aspect of sexual function is affected
• whether sexual desire remains intact
• whether the concern is primarily genital arousal
• whether antidepressant medication is involved
• menopausal status
• other medical contributors
• psychological or relationship factors
• the sildenafil formulation being studied

That complexity helps explain why one trial involving hundreds of women found no significant benefit while more narrowly selected trials reported positive findings.

So the question:

“Does Viagra work for women?”

may be too broad.

A more useful question is:

“What aspect of sexual function has changed?”

Is Viagra a Treatment for HSDD?

No. Viagra is not FDA-approved for HSDD.

HSDD involves persistent low sexual desire associated with significant distress and meeting specific clinical criteria.

In 2026, there are FDA-approved medications with specific female HSDD indications, although their patient populations and dosing are very different.

Addyi® — Flibanserin

Addyi is currently FDA-approved for women under age 65 with acquired, generalized HSDD who meet the labeled criteria.

Its indication was expanded in December 2025 and now includes eligible postmenopausal women under 65 as well as premenopausal women.

Addyi is taken once daily at bedtime.

Vyleesi® — Bremelanotide

Vyleesi is FDA-approved for premenopausal women with acquired, generalized HSDD who meet the labeled criteria.

It is administered as an as-needed subcutaneous injection at least 45 minutes before anticipated sexual activity.

Vyleesi is not indicated for postmenopausal women or for enhancing sexual performance.

These treatments should not simply be described as versions of “female Viagra.”

They have different:

• mechanisms
• indications
• dosing schedules
• safety considerations
• evidence bases

Related reading: Low Libido in Women: Causes, HSDD and Treatment Options in 2026

Viagra vs. Addyi vs. Vyleesi: What's the Difference?

The easiest way to understand the distinction is to ask what problem each medication is intended to address.

Viagra® / Sildenafil

Drug class: PDE5 inhibitor
FDA sexual-health indication: Erectile dysfunction
Female sexual dysfunction: Not FDA-approved
Primary pathway: PDE5 / nitric oxide / cGMP vascular pathway
Female evidence: Mixed; studied particularly in arousal-related and selected medication-associated sexual difficulties

Addyi® / Flibanserin

FDA indication: Acquired, generalized HSDD in women under age 65 meeting the labeled criteria
Dosing: Once daily at bedtime
Primary issue addressed by indication: Low sexual desire associated with HSDD

Vyleesi® / Bremelanotide

FDA indication: Acquired, generalized HSDD in premenopausal women meeting the labeled criteria
Dosing: As-needed subcutaneous injection
Primary issue addressed by indication: Low sexual desire associated with HSDD

So:

Viagra is not simply the male version of Addyi or Vyleesi.

And Addyi and Vyleesi are not simply “Viagra for women.”

Is There Really a “Female Viagra”?

Not in the literal sense.

The phrase “female Viagra” is catchy, but medically it creates more confusion than clarity.

Viagra targets a PDE5-mediated vascular pathway involved in erectile response.

Female sexual concerns can involve:

• desire
• subjective arousal
• genital arousal
• orgasm
• pain
• medication effects
• hormonal changes
• psychological factors
• relationship context

No single medication addresses all of those.

Even the medications specifically approved for female HSDD are not interchangeable with one another.

Calling a treatment “female Viagra” can therefore suggest a simple one-to-one biological equivalent that does not really exist.

What Happens if a Woman Takes Viagra?

Sildenafil remains a pharmacologically active prescription medication when taken by a woman.

Clinical trials in women have reported adverse effects including:

• headache
• flushing
• nasal symptoms
• nausea
• indigestion
• visual disturbances

In the large 2002 female trial, adverse effects were generally described as mild to moderate.

The 2008 antidepressant-associated sexual dysfunction trial also reported effects including headache, flushing and dyspepsia.

Sildenafil has important medication and cardiovascular considerations as well.

Viagra prescribing information lists use with nitrates or nitric-oxide donors as contraindicated because sildenafil can amplify their blood-pressure-lowering effects.

Use with guanylate cyclase stimulators such as riociguat is also contraindicated.

Other medications and health conditions can affect whether sildenafil is appropriate.

That is why taking someone else's Viagra—or using sildenafil specifically for female sexual symptoms without appropriate medical review—is not a substitute for individualized prescribing.

Is Sildenafil Safe for Women?

There is no single answer that applies to every woman.

Women have participated in multiple controlled sildenafil studies, including:

• the 781-woman oral trial
• the 202-woman postmenopausal study
• the 98-woman antidepressant-associated sexual dysfunction trial
• the 2024 topical sildenafil study

But Viagra itself does not have an FDA-approved female sexual-dysfunction indication.

A clinician considering an off-label use would need to evaluate factors such as:

• cardiovascular history
• blood pressure
• current medications
• nitrate use
• other drug interactions
• the sexual concern being evaluated
• other relevant medical conditions

Off-label prescribing is not the same thing as a treatment being FDA-approved for that use.

Frequently Asked Questions

Can Women Take Viagra?

Sildenafil has been studied and prescribed off-label in women, but Viagra is not FDA-approved to treat female sexual dysfunction.

Whether sildenafil is appropriate for an individual woman requires clinical assessment rather than assuming that a medication used for male erectile dysfunction has the same role in female sexual function.

Does Viagra Increase Female Libido?

It should not be considered a general female libido treatment.

Sildenafil primarily acts on a PDE5-mediated vascular pathway, while sexual desire can involve biological, psychological, medication-related and interpersonal factors.

Clinical studies also suggest that sildenafil responses may differ between women with primarily genital-arousal difficulties and women whose main concern is low desire.

Does Viagra Make Women More Aroused?

Research is mixed.

Some carefully selected studies of women with female sexual arousal difficulties reported improvements.

A much larger trial involving 781 women, however, found no significant overall efficacy advantage over placebo.

Physical genital arousal and subjective sexual desire should not be treated as the same outcome.

Can Viagra Help Women Reach Orgasm?

Sildenafil has been studied in women experiencing orgasm difficulties, including women with antidepressant-associated sexual dysfunction.

But it is not FDA-approved as a treatment for female orgasmic disorder, and the available evidence does not establish a predictable orgasm-enhancing effect for women generally.

Can Viagra Help Sexual Side Effects From Antidepressants?

A randomized controlled trial involving 98 women with serotonin reuptake inhibitor-associated sexual dysfunction found better sexual-function outcomes with sildenafil than placebo.

That was a specific population and does not mean sildenafil is appropriate for every woman experiencing antidepressant-related sexual symptoms.

Antidepressant treatment should not be stopped or changed without discussing the issue with the prescribing healthcare professional.

Does Viagra Work for Women After Menopause?

Studies have produced conflicting results.

One randomized trial involving 202 carefully selected postmenopausal women with female sexual arousal disorder reported benefit.

A larger trial involving 781 women found no significant overall benefit.

Menopausal status alone therefore does not predict whether sildenafil would be relevant.

Is Viagra Approved for Women?

No.

Viagra's FDA-approved sexual-health indication is erectile dysfunction.

It is not FDA-approved for female sexual dysfunction, female low libido, HSDD or female orgasm difficulties.

What Is the Difference Between Viagra and “Female Viagra”?

There is no direct female equivalent of Viagra.

Sildenafil targets a PDE5-mediated vascular pathway.

FDA-approved female HSDD treatments such as Addyi and Vyleesi have different mechanisms, indications, dosing schedules and safety profiles.

Is Addyi the Same as Viagra for Women?

No.

Addyi contains flibanserin and is FDA-approved for acquired, generalized HSDD in women under age 65 who meet the labeled criteria.

Viagra contains sildenafil and is FDA-approved for erectile dysfunction.

They are different medications intended for different clinical situations.

Is Vyleesi the Same as Viagra for Women?

No.

Vyleesi contains bremelanotide and is FDA-approved for acquired, generalized HSDD in certain premenopausal women.

Viagra contains sildenafil and has a different mechanism and FDA-approved indication.

Is Topical Sildenafil Cream the Same as Viagra?

No.

The 2024 clinical trial studied an investigational 3.6% topical sildenafil cream.

That is a different formulation and route of administration from oral Viagra.

The trial randomized 200 women, of whom 174 completed the study. It did not show statistically significant differences on the coprimary or secondary efficacy endpoints in the overall intention-to-treat population, although an exploratory subgroup showed encouraging signals.

Results from topical sildenafil should therefore not automatically be applied to oral Viagra.

The Real Question Is: What Has Changed?

“Can women take Viagra?” sounds like a simple medication question.

But the research points toward a more useful question:

What part of sexual function has actually changed?

Is it:

desire?

subjective arousal?

physical genital response?

orgasm?

comfort?

or a medication-related change?

Sildenafil has produced different results depending on which of those problems researchers were actually studying.

That helps explain why some clinical trials reported benefit while others found none.

And it is why female sexual health should not be reduced to the assumption that increasing blood flow automatically increases desire.

Related reading: Low Libido in Women: Causes, HSDD and Treatment Options in 2026

Related reading: Testosterone for Women and Libido: Does It Help? What the Evidence Says in 2026

Related reading: PT-141 vs. Sildenafil vs. Tadalafil: What's the Difference?

AmalfiDuo Sexual Wellness Programs

Explore private, provider-guided sexual wellness programs designed around your needs and goals.

If you choose to move forward, you can complete a secure online health evaluation. A licensed clinician will review your information and determine whether treatment may be appropriate for you.

Explore Sexual Wellness Programs

A prescription is never guaranteed.

‍

‍

References

1. VIAGRA® (sildenafil citrate) — U.S. Prescribing Information. FDA-approved labeling covering indication, pharmacology, contraindications and drug interactions.
2. Basson R, McInnes R, Smith MD, Hodgson G, Koppiker N. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. Journal of Women's Health & Gender-Based Medicine. 2002;11(4):367–377. Randomized trial involving 577 estrogenized and 204 estrogen-deficient women.

https://pubmed.ncbi.nlm.nih.gov/12150499/

3. Berman JR, Berman LA, Toler SM, Gill J, Haughie S. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo-controlled study. Journal of Urology. 2003;170(6 Pt 1):2333–2338. Randomized study involving 202 postmenopausal women with female sexual arousal disorder.

https://pubmed.ncbi.nlm.nih.gov/14634409/

4. Nurnberg HG, Hensley PL, Heiman JR, Croft HA, Debattista C, Paine S. Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial. JAMA. 2008;300(4):395–404. Randomized trial involving 98 women, with 49 assigned to sildenafil and 49 to placebo.

https://pubmed.ncbi.nlm.nih.gov/18647982/

5. Johnson I, Thurman AR, Cornell KA, et al. Preliminary Efficacy of Topical Sildenafil Cream for the Treatment of Female Sexual Arousal Disorder: A Randomized Controlled Trial. Obstetrics & Gynecology. 2024;144(2):144–152. Phase 2b trial randomized 200 women: 101 to sildenafil cream and 99 to placebo; 174 completed the study.

https://pubmed.ncbi.nlm.nih.gov/38889431/

6. Caruso S, Rugolo S, Agnello C, Intelisano G, Di Mari L, Cianci A. Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder. Fertility and Sterility. 2006;85(5):1496–1501.

https://pubmed.ncbi.nlm.nih.gov/16579999/

7. Sipski ML, Rosen RC, Alexander CJ, Hamer RM. Sildenafil effects on sexual and cardiovascular responses in women with spinal cord injury. Urology. 2000;55(6):812–815.

https://pubmed.ncbi.nlm.nih.gov/10840082/

8. ADDYI® (flibanserin) — U.S. Prescribing Information. Current indication includes women under age 65 with acquired, generalized HSDD meeting the labeled criteria.
9. VYLEESI® (bremelanotide) — U.S. Prescribing Information. Current indication is acquired, generalized HSDD in premenopausal women meeting the labeled criteria.

‍

This article is provided for general educational purposes only and is not a substitute for individualized medical advice, diagnosis or treatment. Prescription medications should be used only when prescribed and directed by a qualified healthcare professional. AmalfiDuo Journal articles are written by AmalfiDuo Editorial and are not medically reviewed — see our Editorial Policy.

Sildenafil can interact with medications and health conditions. FDA-approved Viagra labeling contraindicates use with nitrates or nitric-oxide donors and with guanylate cyclase stimulators such as riociguat.

Viagra®, Addyi® and Vyleesi® are trademarks of their respective owners. AmalfiDuo is not affiliated with or endorsed by the owners or manufacturers of these brands.